XML 61 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

 

Common Stock

 

Shelf Registration Statements on Form S-3 and At-The-Market Offering Agreements

 

On February 11, 2022, the Company entered into an At-The-Market Offering Agreement, or sales agreement, with H.C. Wainwright & Co., LLC relating to shares of its common stock. In accordance with the terms of the sales agreement, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $750,000 thousand from time to time through Wainwright acting as its sales agent. As of March 31, 2023, the Company has sold 63,498,908 shares of common stock for an aggregate purchase price of $524,781 thousand, net of offering costs, pursuant to this At-The-Market Offering Agreement.

 

Common Stock Warrants

 

As of March 31, 2023 and December 31, 2022, the Company had 324,375 issued and outstanding stock warrants.

 

Restricted Stock

 

A summary of the restricted stock award activity (represented by restricted stock units (RSUs) for the three months ended March 31, 2023 is as follows:

 

   Number of Units   Weighted Average Grant Date Fair Value 
Nonvested at December 31, 2022   1,255,648   $22.60 
Granted   662,865    6.86 
Vested   (418,259)   17.56 
Nonvested at March 31, 2023   1,500,254   $17.05